---
reference_id: "PMID:40254346"
title: Renal ciliopathies.
authors:
- Devlin LA
- Dewhurst RM
- Sudhindar PD
- Sayer JA
journal: Curr Top Dev Biol
year: '2025'
doi: 10.1016/bs.ctdb.2025.01.009
content_type: abstract_only
---

# Renal ciliopathies.
**Authors:** Devlin LA, Dewhurst RM, Sudhindar PD, Sayer JA
**Journal:** Curr Top Dev Biol (2025)
**DOI:** [10.1016/bs.ctdb.2025.01.009](https://doi.org/10.1016/bs.ctdb.2025.01.009)

## Content

1. Curr Top Dev Biol. 2025;163:229-305. doi: 10.1016/bs.ctdb.2025.01.009. Epub
2025  Mar 18.

Renal ciliopathies.

Devlin LA(1), Dewhurst RM(1), Sudhindar PD(1), Sayer JA(2).

Author information:
(1)Translational and Clinical Research Institute, Faculty of Medical Sciences, 
Newcastle University, Newcastle upon Tyne, United Kingdom.
(2)Biosciences Institute, Faculty of Medical Sciences, Newcastle University, 
Newcastle upon Tyne, United Kingdom; Renal Services, Newcastle upon Tyne NHS 
Foundation Trust, Newcastle upon Tyne, United Kingdom; National Institute for 
Health Research, Newcastle Biomedical Research Centre, Newcastle Upon Tyne, 
United Kingdom. Electronic address: john.sayer@newcastle.ac.uk.

Primary cilia are essential cellular organelles with pivotal roles in many 
signalling pathways. Here we provide an overview of the role of primary cilia 
within the kidney, starting with primary ciliary structure and key protein 
complexes. We then highlight the specialised functions of primary cilia, 
emphasising their role in a group of diseases known as renal ciliopathies. These 
conditions include forms of polycystic kidney disease, nephronophthisis, and 
other syndromic ciliopathies, such as Joubert syndrome and Bardet-Biedl 
syndrome. We explore models of renal ciliopathies, both in vitro and in vivo, 
shedding light on the molecular mechanisms underlying these diseases including 
Wnt and Hedgehog signalling pathways, inflammation, and cellular metabolism. 
Finally, we discuss therapeutic approaches, from current treatments to 
cutting-edge preclinical research and clinical trials.

Copyright Â© 2025. Published by Elsevier Inc.

DOI: 10.1016/bs.ctdb.2025.01.009
PMID: 40254346 [Indexed for MEDLINE]